当前位置: X-MOL首页全球导师 国内导师 › 齐忠权

个人简介

齐忠权,1979-1984哈尔滨医科大学医疗系读大学 1994-1999瑞典隆德大学医学院读博士 1999-2001瑞典隆德大学马尔默医院博士后 工作经历 1984-1991哈尔滨医科大学附属第一医院外科:住院医师和助教 1991-1993哈尔滨医科大学附属第一医院外科:主治医师和讲师 1993-1999瑞典隆德大学马尔默医院外科:外科博士,客座医生 1999-现在瑞典隆德大学马尔默医院移植外科:研究员,移植医生 2000-现在哈尔滨医科大学,教授。 2003-现在哈尔滨医科大学博士生导师 2006-2017厦门大学医学院教授,博士生导师,厦门大学医学院副院长,厦门大学器官 移植研究所所长 2008-2010厦门大学医院院长 2007-2012厦门大学附属中山医院胃肠外科主任(兼) 2011-现在哈尔滨医科大学附属第一医院副院长(兼) 2013-现在厦门大学附属福州二院副院长(兼) 2017-现在广西大学医学院院长,教授,博士生导师 获奖情况 1991黑龙江省科技进步一等奖:“部分脾脏切除术” 1993黑龙江省科技进步一等奖:“世界首例父子间异体劈裂脾移植” 1995瑞典科技年会奖:“抗CD4单克隆抗体对大鼠心脏移植的抗排究” 20062006年入典美国医学卫生保健世界名人传记《Who’sWhoIn MedicineAndHealthcare》第7版年鉴。 2008厦门市五一劳动奖章、厦门市及福建省援川抗震救灾先进个人、福建省优秀 共产党员、第五届中国医师奖提名奖 2011卢嘉锡优秀导师奖 2012国家重大科学研究计划重大基础研究导向项目课题首席负责人 2014科学中国人(2013)年度人物主讲课程外科学、局部解剖学等主持(或参与)的主要科研项目1板蓝根组酸单体抗移植排斥及抗肿瘤双重作用的研究(2010Y0052)福建省科学技术厅,重点项目30万2010-03~2012-02 2博士点建设与申报专项经费厦门大学医学院“985”二期博士点建设与申报专项经费165万2009-08~2012-08 3N,N’-二环己基-N-山嵛酸酰脲抗急、慢性移植排斥的效果及机制研究(2011J01253)福建省科技计划面上项目12万2011-04~2014-04 4异种异源细胞和器官的灵长类动物移植探索及其免疫学基础(2012CBA01303)中国科学技术部,重大科学问题目标导向项目1600万2012-01~2016-12 5基于灵长类动物的"异种AVM-自体MSC"组织工程血管构建及BMP2促血管生成机制研究(31271038)国家自然科学基金委员会,面上项目80万2013-01~2016-12 6基于树异种移植动物模型建立及免疫排斥机制的研究(81441047)国家自然科学基金委员会,应急项目10万2015-01~2015-12 7生态级负离子和远红外线对于人体器官、组织和细胞再生与修复的研究厦门海思王光电科技有限公司100万元2015-09~2020-08

研究领域

移植免疫,免疫排斥机理,核移植与再生医学

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

1.LiC,LengY,ZhaoB,GaoC,DuF,JinN,LianQ,XuS,YanG,XiaJ,ZhuangG,FuQ,QiZ.HumaniPSC-MSC-DerivedXenograftsModulateImmuneResponsesbyInhibitingtheCleavageofCaspases,StemCell,2017,35(7):179-1732. 2.LinY,ChenW,LiJ,YanG,LiC,JinN,ChenJ,GaoC,MaP,XuS,QiZ.OverexpressionofJagged-1combinedwithblockadeofCD40pathwayprolongsallograftsurvival.ImmunolCellBiol.2015,93(2):213-217. 3.LiC,GuanT,GaoC,LinY,YanG,ZhuM,LvC,XiaJ,QiZ.ArsenictrioxideinhibitsacceleratedallograftrejectionmediatedbyalloreactiveCD8+memoryTcellsandprolongsallograftsurvivaltime.TransplImmunol.2015,33(1):30-36. 4.GaoC,JiangJ,MaP,ChengP,LianY,ZhaoB,LiC,PengY,WangF,LinY,JinN,LiJ,WangL,LiQ,LengY,XiaJ,QiZ.ArsenicTrioxideInducesTCellApoptosisandProlongsIsletAllograftSurvivalinMice.Transplantation.2015,99(9):1796-1806. 5.ChengPP,LiuXC,MaPF,GaoC,LiJL,LinYY,ShaoW,HanS,ZhaoB,WangLM,FuJZ,MengLX,LiQ,LianQ,XiaJJ,QiZQ.Mesenchymalstemcellsderivedfrominducedpluripotentstemcellscombinedwithlow-doserapamycininducedisletallografttoleranceviasuppressingTh1andenhancingregulatoryTcelldifferentiation.StemCellsDev.2015,24(15):1793-1804. 6.WuY,XuS,GuoH,YanG,QiZ,ShanZ.Ectopicdrainagefromtheinferiorvenacavatotheleftatriumtogetherwithapartialanomalouspulmonaryvenousconnection.AnnVascSurg.2014,28(5):1313.e9-1313.e11. 7.WuY,BinY,YanG,XuS,ChengP,HuangH,ZhengJ,QiZ.Sizediscrepancy:notaformidableprobleminamouseheterotopicaortictransplant.ExpClinTransplant.2014,12(4):367-370. 8.Peng-FeiMa,JieJiang,ChangGao,Pan-PanCheng,Jia-LiLi,XinHuang,Ying-YingLin,QingLi,Yuan-ZhengPeng,Mei-ChunCai,WeiShao,QiZhu,SaiHan,QingQin,Jun-JieXia,andZhong-QuanQi.ImmunosuppressiveEffectofCompoundKonIsletTransplantationinaSTZ-InducedDiabeticMouseModel.Diabetes,2014,63(10):3458-3469. 9.YuLiu,Xiao-QinHe,XinHuang,LuDing,LinXu,Yu-TingShen,FeiZhang,Mao-BiZhu,Bai-HuiXu,Zhong-QuanQi,Hai-LongWang.ResveratrolProtectsMouseOocytesfromMethylglyoxal-InducedOxidativeDamage,PLOSONE,2013,8(10):e77960. 10.YanG.,XiY.,XuS.,ChenJ.,LinY.,DaiH.,ChengP.,XiaoH.,LiuZ.,andQiZ.,InhibitingacceleratedrejectionmediatedbyalloreactiveCD4(+)memoryTcellsandprolongingallograftsurvivalby1alpha,25-dihydroxyvitaminD(3)innudemice.ImmunolLett,2013,149(1-2):54-61. 11.PahlmanC.,QiZ.,MurrayC.M.,FergusonD.,BundickR.V.,DonaldD.K.,andEkbergH.,ImmunosuppressivepropertiesofaseriesofnovelinhibitorsofthemonocarboxylatetransporterMCT-1.TransplInt,2013,26(1):22-29. 12.ZhangS.,RahmanM.,ZhangS.,HerwaldH.,QiZ.,JeppssonB.,andThorlaciusH.,StreptococcalM1protein-provokedCXCchemokineformation,neutrophilrecruitmentandlungdamageareregulatedbyRho-kinasesignaling.JInnateImmun,2012,4(4):399-408. 13.WuT.,SunC.,ChenZ.,ZhenY.,PengJ.,QiZ.,YangX.,andZhaoY.,Smad3-deficientCD11b(+)Gr1(+)myeloid-derivedsuppressorcellspreventallograftrejectionviathenitricoxidepathway.JImmunol,2012.189(10):4989-5000. 14.PalaniK.,RahmanM.,HasanZ.,ZhangS.,QiZ.,JeppssonB.,andThorlaciusH.,Rho-kinaseregulatesadhesiveandmechanicalmechanismsofpulmonaryrecruitmentofneutrophilsinabdominalsepsis.EurJPharmacol,2012.682(1-3):181-7. 15.HuangX.,DingL.,PanR.,MaP.F.,ChengP.P.,ZhangC.H.,ShenY.T.,XuL.,LiuY.,HeX.Q.,QiZ.Q.,andWangH.L.,WHAMMisrequiredformeioticspindlemigrationandasymmetriccytokinesisinmouseoocytes.HistochemCellBiol,2013,139(4):525-534. 16.DingL.,PanR.,HuangX.,WangJ.X.,ShenY.T.,XuL.,ZhangY.,LiuY.,HeX.Q.,YangX.J.,QiZ.Q.,andWangH.L.,Changesinhistoneacetylationduringoocytemeioticmaturationinthediabeticmouse.Theriogenology,2012,78(4):784-792. 17.ZhangS.,RahmanM.,ZhangS.,QiZ.,andThorlaciusH.,SimvastatinantagonizesCD40Lsecretion,CXCchemokineformation,andpulmonaryinfiltrationofneutrophilsinabdominalsepsis.JLeukocBiol,2011,89(5):735-742. 18.ZhangS.,RahmanM.,ZhangS.,QiZ.,HerwaldH.,andThorlaciusH.,SimvastatinregulatesCXCchemokineformationinstreptococcalM1protein-inducedneutrophilinfiltrationinthelung.AmJPhysiolLungCellMolPhysiol,2011.300(6):L930-1939. 19.WangY.,ChangH.,ZouJ.,JinX.,andQiZ.,TheeffectofatorvastatinonmRNAlevelsofinflammatorygenesexpressioninhumanperipheralbloodlymphocytesbyDNAmicroarray.BiomedPharmacother,2011.65(2):p.118-22. 20.WangF.,ChenJ.,ShaoW.,KangX.,XuS.,XiaJ.,DaiH.,PengY.,ThorlaciusH.,XingJ.,andQiZ.,Themajorhistocompatibilitycomplex(MHC)ofthesecondarytransplanttissuedonorinfluencesthecross-reactivityofalloreactivememorycells.ScandJImmunol,2011.73(3):p.190-7. 21.ShaoW.,YanG.,LinY.,ChenJ.,DaiH.,WangF.,XiY.,ThorlaciusH.,andQiZ.,CD44/CD70blockadeandanti-CD154/LFA-1treatmentsynergisticallysuppressacceleratedrejectionandprolongcardiacallograftsurvivalinmice.ScandJImmunol,2011.74(5):p.430-7. 22.ShaoW.,ChenJ.,DaiH.,PengY.,WangF.,XiaJ.,ThorlaciusH.,ZhuQ.,andQiZ.,CombinationofmonoclonalantibodieswithDSTinhibitsacceleratedrejectionmediatedbymemoryTcellstoinducelong-livedheartallograftacceptanceinmice.ImmunolLett,2011.138(2):p.122-8. 23.QiuX.F.,LinL.,YuanS.B.,YanF.,DingZ.J.,BaiL.P.,YeZ.J.,LinW.J.,QiZ.Q.,andLiuZ.C.,[Transumbilicalsingle-portaccesslaparoscopicsurgeryforcolorectalcancer].ZhonghuaWeiChangWaiKeZaZhi,2011.14(1):p.34-6. 24.PengY.,ChenJ.,ShaoW.,WangF.,DaiH.,ChengP.,XiaJ.,WangF.,HuangR.,ZhuQ.,andQiZ.,XenoreactiveCD4+memoryTcellsresistinhibitionbyanti-CD44mAbandrejectisletgraftsviaaTh2-dependentpathway.Xenotransplantation,2011.18(4):p.252-61. 25.LinY.,DaiH.,SuJ.,YanG.,XiY.,EkbergH.,ChenJ.,andQiZ.,Arsenictrioxideisanovelagentforcombinationtherapytoprolongheartallograftsurvivalinallo-primedTcellstransferredmice.TransplImmunol,2011.25(4):p.194-201. 26.HuangY.L.,WangY.Z.,ChenJ.B.,WangF.,KangX.P.,XiaJ.J.,LanT.S.,XieB.Y.,EkbergH.,WangX.M.,andQiZ.Q.,Preventionofacuteandchronicallograftrejectionbycombinationsoftolerogenicdendriticcells.ScandJImmunol,2011.73(2):p.91-101. 27.HuangX.,WangH.L.,QiS.T.,WangZ.B.,TongJ.S.,ZhangQ.H.,OuyangY.C.,HouY.,SchattenH.,QiZ.Q.,andSunQ.Y.,DYNLT3isrequiredforchromosomealignmentduringmouseoocytemeioticmaturation.ReprodSci,2011.18(10):p.983-9. 28.HuangX.,TongJ.S.,WangZ.B.,YangC.R.,QiS.T.,GuoL.,OuyangY.C.,QuanS.,SunQ.Y.,QiZ.Q.,HuangR.X.,andWangH.L.,JNK2participatesinspindleassemblyduringmouseoocytemeioticmaturation.MicroscMicroanal,2011.17(2):p.197-205. 29.DaiH.,ChenJ.,ShaoW.,WangF.,XuS.,PengY.,LinY.,XiaJ.,EkbergH.,WangX.,andQiZ.,BlockadeofCD27/CD70pathwaytoreducethegenerationofmemoryTcellsandmarkedlyprolongthesurvivalofheartallograftsinpresensitizedmice.TransplImmunol,2011.24(4):p.195-202. 30.ChengP.P.,XiaJ.J.,WangH.L.,ChenJ.B.,WangF.Y.,ZhangY.,HuangX.,ZhangQ.J.,andQiZ.Q.,Islettransplantationreversestheeffectsofmaternaldiabetesonmouseoocytes.Reproduction,2011.141(4):p.417-24. 31.ZhaoY.,ZhangS.,ZhouJ.,WangJ.,ZhenM.,LiuY.,ChenJ.,andQiZ.,Thedevelopmentofatissue-engineeredarteryusingdecellularizedscaffoldandautologousovinemesenchymalstemcells.Biomaterials,2010.31(2):p.296-307. 32.XuS.,ChenJ.,WangF.,KangX.,LanT.,WangF.,LiZ.,QiZ.,andXingJ.,Arsenictrioxidecombinedwithco-stimulatorymoleculeblockadeprolongssurvivalofcardiacallograftsinalloantigen-primedmice.TransplImmunol,2010.24(1):p.57-63. 33.XieB.,ChenJ.,WangF.,LanT.,WangY.,XiaJ.,LiZ.,XieQ.,HuangR.,andQiZ.,Monoclonalantibodytreatmenttoprolongthesecondarycardiacallograftsurvivalinalloantigen-primedmice.ScandJImmunol,2010.71(5):p.345-52. 34.XiaJ.,ChenJ.,ShaoW.,LanT.,WangY.,XieB.,ThorlaciusH.,TianF.,HuangR.,andQiZ.,SuppressingmemoryTcellactivationinducesisletallografttoleranceinalloantigen-primedmice.TransplInt,2010.23(11):p.1154-63. 35.WangF.,XiaJ.,ChenJ.,PengY.,ChengP.,EkbergH.,WangX.,andQiZ.,CombinationofantibodiesinhibitsacceleratedrejectionmediatedbymemoryTcellsinxenoantigen-primedmice.Xenotransplantation,2010.17(6):p.460-8. 36.WangF.,ChenJ.,ShaoW.,XieB.,WangY.,LanT.,ThorlaciusH.,andQiZ.,Anti-CD44monoclonalantibodyinhibitshearttransplantrejectionmediatedbyalloantigen-primedCD4(+)memoryTcellsinnudemice.ImmunolInvest,2010.39(8):p.807-19. 37.SuZ.,XiaJ.,ShaoW.,CuiY.,TaiS.,EkbergH.,CorbascioM.,ChenJ.,andQiZ.,Smallisletsareessentialforsuccessfulintraportaltransplantationinadiabetesmousemodel.ScandJImmunol,2010.72(6):p.504-10. 38.ShaoW.,ChenJ.B.,WangF.,XiaJ.J.,andQiZ.Q.,CombinedapplicationofblockingantibodiesandMicroRNAinterferenceininhibitingCD44expression.TransplantProc,2010.42(7):p.2777-81. 39.LiangH.,ZhaoY.,SanZ.,LiaoC.,ShaC.,XieB.,ChenJ.,XiaJ.,WangY.,andQiZ.,TherecallalloresponsefollowingretransplantationismoreintensecomparedwiththeTcellmemory-transfermodel.ImmunolInvest,2010.39(1):p.39-53. 40.LiangH.,LiaoC.,QiZ.,ShaC.,XieB.,ChenJ.,XiaJ.,WangY.,YaoQ.,andZhaoY.,RapamycinortacrolimusalonefailstoresistcardiacallograftacceleratedrejectionmediatedbyalloreactiveCD4(+)memoryTcellsinmice.TransplImmunol,2010.22(3-4):p.128-36. 41.LanT.,ChenJ.,XiaJ.,WangY.,XieB.,WangF.,andQiZ.,Inhibitionofalloantigen-primedmemoryCD4+andCD8+Tcellsbyhematopoieticchimerisminmice.ScandJImmunol,2010.72(2):p.86-93. 42.KangX.,ChenJ.,QinQ.,WangF.,WangY.,LanT.,XuS.,WangF.,XiaJ.,EkbergH.,QiZ.,andLiuZ.,IsatistinctoriaL.combinedwithco-stimulatorymoleculesblockadeprolongssurvivalofcardiacallograftsinalloantigen-primedmice.TransplImmunol,2010.23(1-2):p.34-9. 43.ChenJ.,XiaJ.,AxelssonB.,FritzsonI.,EkbergH.,TorngrenM.,andQiZ.,AnN-(alkylcarbonyl)anthranilicacidderivativeprolongscardiacallograftsurvivalsynergisticallywithcyclosporineAinahigh-responderratmodel.TransplImmunol,2010.23(4):p.180-4. 44.XieB.,ChenJ.,XiaJ.,WangY.,LiangH.,EkbergH.,CorbascioM.,andQiZ.,Combinedcostimulationblockadeinhibitsacceleratedrejectionmediatedbyalloantigen-primedmemoryTcellsinmice.ImmunolInvest,2009.38(7):p.639-51. 45.WangY.,QinQ.,ChenJ.,KuangX.,XiaJ.,XieB.,WangF.,LiangH.,andQiZ.,SynergisticeffectsofIsatistinctoriaL.andtacrolimusinthepreventionofacuteheartrejectioninmice.TransplImmunol,2009.22(1-2):p.5-11. 46.ChenX.,ShaoW.,ChenJ.B.,ZhangL.,MatthiasC.,ShanS.G.,andQiZ.Q.,Allotransplantationofsulphateglucomannan-alginatebarium(SGA)-microencapsulatedratisletsforthetreatmentofdiabetesmellitus.ImmunolInvest,2009.38(7):p.561-71. 47.PahlmanC.,MalmH.,QiZ.,VeressB.,FergusonD.,BundickR.,MurrayC.,DonaldD.,andEkbergH.,OperationaltoleranceinnonvascularizedtransplantmodelsinducedbyAR-C117977,amonocarboxylatetransporterinhibitor.Transplantation,2008.86(8):p.1135-8. 48.EkbergH.,QiZ.,PahlmanC.,VeressB.,BundickR.V.,CraggsR.I.,HolnessE.,EdwardsS.,MurrayC.M.,FergusonD.,KerryP.J.,WilsonE.,andDonaldD.K.,Thespecificmonocarboxylatetransporter-1(MCT-1)inhibitor,AR-C117977,inducesdonor-specificsuppression,reducingacuteandchronicallograftrejectionintherat.Transplantation,2007.84(9):p.1191-9. 49.OderupC.,MalmH.,EkbergH.,QiZ.,VeressB.,IvarsF.,andCorbascioM.,Costimulationblockade-inducedcardiacallografttolerance:inhibitionofTcellexpansionandaccumulationofintragraftcD4(+)Foxp3(+)Tcells.Transplantation,2006.82(11):p.1493-500. 50.ZhangL.,QiZ.,WuD.,ShanS.,andEkbergH.,Additiveeffectsofleflunomideandtacrolimusinpreventionofisletxenograftrejection.ScandJImmunol,2004.59(3):p.255-60. 51.ZainaS.,PetterssonL.,ThomsenA.B.,ChaiC.M.,QiZ.,ThybergJ.,andNilssonJ.,Shortenedlifespan,bradycardia,andhypotensioninmicewithtargetedexpressionofanIgf2transgeneinsmoothmusclecells.Endocrinology,2003.144(6):p.2695-703. 52.CorbascioM.,MahantyH.,OsterholmC.,QiZ.,PearsonT.C.,LarsenC.P.,FreiseC.E.,andEkbergH.,Anti-lymphocytefunction-associatedantigen-1monoclonalantibodyinhibitsCD40ligand-independentimmuneresponsesandpreventschronicvasculopathyinCD40ligand-deficientmice.Transplantation,2002.74(1):p.35-41. 53.CorbascioM.,EkstrandH.,OsterholmC.,QiZ.,SimanaitisM.,LarsenC.P.,PearsonT.C.,RiesbeckK.,andEkbergH.,CTLA4Igcombinedwithanti-LFA-1prolongscardiacallograftsurvivalindefinitely.TransplImmunol,2002.10(1):p.55-61. 54.OsterholmC.,QiZ.,EkbergJ.,VeressB.,PykeC.,HednerU.,andEkbergH.,Initialinhibitionoftissuefactorsignallingreduceschronicvascularchangesinisogenicrataortictransplants.AmJTransplant,2001.1(1):p.29-37. 55.ErikssonT.,WallinR.,HoglundP.,RothB.,QiZ.,OstraatO.,andBjorkmanS.,Lowbioavailabilityofrectallyadministeredthalidomide.AmJHealthSystPharm,2000.57(17):p.1607-10. 56.QiZ.,TufvesonG.,andEkbergH.,Toleranceorrejection:Adelicatebalanceasjudgedbyexposureofheart-transplantedratstotheimmunomodulatorLinomide.ScandJImmunol,1999.50(4):p.394-8. 57.QiZ.,SimanaitisM.,andEkbergH.,Malononitrilamidesandtacrolimusadditivelypreventacuterejectioninratcardiacallografts.TransplImmunol,1999.7(3):p.169-75. 58.OlaussonM.,LukesD.,NorrbyJ.,QiZ.,EkbergH.,GannedahlG.,TufvesonG.,andMjornstedtL.,AntithymocyteglobulinandcyclosporinAaresynergisticinanexperimentaltransplantationtolerancemodelintherat.ScandJImmunol,1999.49(1):p.38-44. 59.QiZ.,SimanaitisM.,andEkbergH.,Malononitrilamides715and279preventacceleratedcardiacallograftrejectionsynergisticallywithcyclosporinAinpresensitizedrats.TransplImmunol,1998.6(2):p.94-100. 60.QiZ.andEkbergH.,Malononitrilamidespreventandsuppressallospecificantibodyproduction.TransplantProc,1998.30(8):p.3980. 61.QiZ.andEkbergH.,Malononitrilamides715and279prolongratcardiacallograftsurvival,reverseongoingrejection,inhibitallospecificantibodyproductionandinteractpositivelywithcyclosporin.ScandJImmunol,1998.48(4):p.379-88. 62.PeterssonE.,QiZ.,HedlundG.,andEkbergH.,Activationofdonor-specificCTLinatolerantrecipientofcardiacallograft.CellImmunol,1998.189(1):p.19-24. 63.QiZ.,RiesbeckK.,OstraatO.,TufvesonG.,andEkbergH.,Singledoseanti-CD4monoclonalantibodyforinductionoftolerancetocardiacallograftinhigh-andlow-responderratstraincombinations.TransplImmunol,1997.5(3):p.204-11. 64.PeterssonE.,QiZ.,EkbergH.,OstraatO.,DohlstenM.,andHedlundG.,Activationofalloreactivenaturalkillercellsisresistanttocyclosporine.Transplantation,1997.63(8):p.1138-44. 65.OstraatO.,QiZ.,OlaussonM.,TufvesonG.,andEkbergH.,Mycophenolatemofetil,azathioprineandcyclophosphamideenhancedefficacycombinedwithcyclosporineinratcardiactransplantation.ScandJImmunol,1997.45(4):p.343-8. 66.OstraatO.,RiesbeckK.,QiZ.,ErikssonT.,SchatzH.,andEkbergH.,Thalidomideprolongedgraftsurvivalinaratcardiactransplantmodelbuthadnoinhibitoryeffectonlymphocytefunctioninvitro.TransplImmunol,1996.4(2):p.117-25. 67.OstraatO.,QiZ.,GannedahlG.,TufvesonG.,andEkbergH.,ModerateadditiveimmunosuppressiveeffectofthalidomidecombinedwithcyclosporinAinratcardiactransplantation.TransplImmunol,1996.4(3):p.241-6. 68.BojrupM.,QiZ.,BjorkmanS.,OstraatO.,LandinB.,Ljusberg-WahrenH.,andEkbergH.,Bioavailabilityofcyclosporineinratsafterintragastricadministration:acomparativestudyoftheL2-phaseandtwootherlipid-basedvehicles.TransplImmunol,1996.4(4):p.313-7. 69.BjorkmanS.,FygeA.,andQiZ.,Determinationofthesteadystatetissuedistributionofmidazolamintherat.JPharmSci,1996.85(8):p.887-9. 70.OstraatO.,QiZ.,OlaussonM.,GannedahlG.,TufvesonG.,andEkbergH.,AdditiveimmunosuppressiveeffectofcombinedmycophenolatemofetilandcyclosporinAinexperimentalratcardiactransplantation.TransplantProc,1995.27(6):p.3540. 71.OlaussonM.,ArvidssonN.,LukesD.,MjornstedtL.,QiZ.,EkbergH.,GannedahlG.,andTufvesonG.,InhibitionofATG-inducedexperimentaltransplantationtolerancewithLS2616.TransplantProc,1995.27(6):p.3541-3.

学术兼职

2007-现在国际器官移植学会(TTS)会员 2007-现在厦门市医师学会常务理事 2008-现在福建省医学会器官移植分会副主任委员 2012-现在中华医学会泌尿肾移植学组委员 2013-现在中国免疫学学会移植免疫分会委员 2014-现在中国研究型医院学会移植医学专业委员会委员 2015-现在中国修复重建外科专业委员会再生医学转化学组委员 社会工作 2008-现在国务院侨办海外专家咨询委员会第二、三、四届委员 2013-现在福建省侨办海外专家顾问团高级顾问

推荐链接
down
wechat
bug